Skip to main content

GTS Securities LLC

SEC CIK
0001452765
Latest filing
Aug 14, 2026

SGMOQ holding history

Sangamo Therapeutics, Inc in every 13F filed by GTS Securities LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SGMOQ overviewAll 13F holders of SGMOQFull Q2 2026 holdings

Shares (Q1 2024)
0
Sold out in Q1 2024
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q3 2023
Holdings of SGMOQ by GTS Securities LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20240$00.0%−12,633−100.0%Sold outHolders
Q4 202312,633$6.86K<0.1%−10,159−44.6%ReducedHolders
Q3 202322,792$13.7K<0.1%+22,792NewHolders